Abstract Submission
The ICBMT2023 Organizing Committee, we extend our warm invitation to submit abstracts for oral and poster presentations at our upcoming conference. We request all interested parties to submit their abstracts through the designated "Online Submission System.“
We assure you that all submitted abstracts will be reviewed meticulously by Scientific Committee. Following the review process, the presentation type may be changed, subject to the decision of the Scientific Committee.
We want to emphasize that abstract submission does not automatically imply registration in the conference. Presenters must individually register for the conference. We urge you to carefully review the guidelines before submitting your abstract.
Important Dates
- -Deadline for Abstract Submission: June 23, 2023 (Extended)
- -Notification of Abstract Acceptance: July 12, 2023
- -Presenter Registration: August 11, 2023
Steps for Abstract Submission
-
Step 1
Review abstract topics and guidelines carefully
-
Step 2
Sign up or log in
-
Step 3
Go to abstract submission
-
Step 4
Fill out author's info
-
Step 5
Complete abstract submission
-
Step 6
Receive submission confirmation email
Abstract Submission Topics
- -Submitted abstracts will be reviewed by the Scientific Program Committee.
| Acute Myeloid Leukemia |
Acute Lymphoblastic Leukemia |
Bone Marrow Failure |
- -Diagnosis and prognostication
- -Treatment including induction treatment, stem cell transplantation and salvage treatment
- -Clinical trials including novel drugs
|
- -Diagnosis and prognostication
- -Treatment including induction treatment, stem cell transplantation and salvage treatment
- -Clinical trials including novel drugs
|
- -Aplastic anemia
- -Myelodysplastic syndrome
- -Other disorders
|
| Cellular & Gene Therapy |
Blood and Marrow Collection and Processing |
Infectious Complications |
- -In vitro and pre-clinical study
- -Clinical trials with cell therapy
- -Gene therapy
|
- -Hematopoietic stem cell collection
- -Mobilization and processing
- -Growth factors and cytokines
|
- -Acute infectious complications related with stem cell transplantation
- -Late infectious complications from transplant survivors
- -Vaccination and prevention of infection
|
| Lymphoma |
Post-transplant Complications
(Non-infectious) |
Myeloma |
- -Genomics of lymphoma
- -Induction and salvage treatment for lymphoma
- -Autologous and allogeneic stem cell transplantation for lymphoma
- --Post-transplantation failure management
|
- -Acute and chronic GVHD
- -Other acute complications
- -Late complications
- -Long-term survivor management
|
- -Genomics of myeloma
- -Induction and salvage treatment for myeloma
- -Autologous and allogeneic stem cell transplantation for myeloma
- -Post-transplantation failure management
|
| Nursing/Allied Health |
Pediatric Hematology/Oncology |
Transplantation Specific Topics |
- -Quality of life
- -Stem cell donation
- -Nursing care for stem cell transplantation
- -Nutritional support
- -Education of post-transplant survivors
|
- -Pediatric hematologic malignancy
- -Pediatric nonmalignant disease
- -Pediatric oncology
|
- -Conditioning regimens
- -Transplantation protocols
- -Cord blood transplantation
- -Haploidentical transplantation
- -Donor selection process
|
| Stem Cell Biology |
Others |
|
- -Cancer stem cells
- -Hematopoietic stem cells
|
|
|
Abstract Submission Guidelines
Theses guidelines are for general participants, not invited speakers.
- -All abstracts must be submitted online prior to June 23, 2023.
- -Abstracts must be written in clear English and presented in English.
- -An abstract consists of a title, author name ‘s and affiliation, the text of the submission and keywords.
| Title |
- -Capitalize the first letter of each word
- -Limited to 150 letters including spaces
|
| Author Information |
- -Name: Write first and family name(s) in full.
- -Affiliation should be structured as follows: Department, Institution, Country
- -Degrees or titles such as MD after an author’s name must be deleted.
|
| Abstract Body |
- -Structured chronologically into four sections: Background, Methods, Results, Conclusions
- -Limited to 3,600 characters including spaces and punctuation
|
| Keywords |
No more than 6 keywords which the first word begins with a capital letter. |
| Tables and Images |
Only one Table or image is allowed. |
Before you click the “submit” button, please review the following information.
- -No additional proofreading or corrections will be allowed after the submission deadline. It is the responsibility of the authors to ensure that their text does not contain typos or grammatical errors.
- -Authors have the option of choosing their presentation type (oral, oral or poster, poster). However, the scientific program committee will make the final decision after review.
- -Acknowledgment of your submission will be sent to the e-mail address provided by the corresponding author. If you do not receive this e-mail confirmation, it means we have not received your abstract. If you are sure you have submitted it, check to make sure you sent it to the correct e-mail address.
- -The e-mail you provided us will be used to notify you of the acceptance and to send you updated information. If you have any inquiries, please contact the secretariat at icbmt@icbmt.or.kr.
Notification of Acceptance
- -All submitted abstracts will be reviewed by the Scientific Program Committee according to reviewing procedures.
- -Notification of acceptance will be sent by e-mail to corresponding, presenting and abstract submitting authors by July 12, 2023.
- -The presenting author should reply to the acceptance notification for confirmation of attendance.
Abstract Withdrawal
- -If the presenting author of an accepted abstract does not register by August 18, 2023, the abstract will be automatically withdrawn from the final program.
- -If you have to withdraw an abstract, please notify the secretariat (icbmt@icbmt.or.kr) in writing as soon as possible.
>
